J&J’s Second Shot Increased Efficacy For Moderate-Severe Covid-19 To 94%, Claims Firm
Johnson & Johnson announced on Tuesday that a second dose of its Covid-19 vaccine enhanced the effectiveness of its first shot to 94 per cent against moderate to severe forms of the disease in the United States if it is administered approximately two months after its first shot. In comparison, its single dose provided a…









